Tag: dna
Gingko Bioworks, valued at $15B, begins trading today: Here’s how their business works
Gingko Bioworks, a synthetic biology company now valued at around $15 billion, begins trading on the New York Stock Exchange today. Gingko’s market debut is one of the largest in biotech history. It’s expected to raise about $1.6 billion for the company. It’s also one of the biggest SPAC deals…
Read More
NVIDIA and Harvard researchers use AI to make genome analysis faster and cheaper
Scientists from NVIDIA and Harvard have made a huge breakthrough in genetic research. They developed a deep-learning toolkit that is able to significantly cut down the time and cost needed to run rare and single-cell experiments. According to a study… Source
Read More
A ferret is the first North American endangered animal to be cloned
Animal cloning might just become a valuable tool in preserving species that might otherwise go extinct. BBC News says US Fish and Wildlife Service has successfully cloned a black-footed ferret — the first genetic copy of a North American endangered s… Source
Read More
Emerging from stealth, Octant is bringing the tools of synthetic biology to large scale drug discovery
Octant, a company backed by Andreessen Horowitz just now unveiling itself publicly to the world, is using the tools of synthetic biology to buck the latest trends in drug discovery. As the pharmaceuticals industry turns its attention to precision medicine — the search for ever more tailored treatments for specific…
Read More
Oxford scientists develop new coronavirus test that provides results in just 30 minutes
Scientists at the University of Oxford have developed a new coronavirus test that produces results around three times faster than the current fastest testing methods, and that requires only relatively simple technical instrumentation. In addition to these benefits, the researchers behind the test’s development say that it could even help…
Read More
Karius raises $165 million for its liquid biopsy technology identifying diseases in a drop of blood
“What Karius is good at is identifying those novel microbes before they become an outbreak like coronavirus,” says Mickey Kertesz, a chief executive whose life sciences startup just hauled in $165 million in new funding. While the new money may have been raised under the looming threat of Covid 19,…
Read More